Exploration of Current and New Technologies for Accuracy of Diagnosing OSA
- Sponsor
- ResMed
- Study ID
- NCT07485582
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Obstructive Sleep Apnea
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Device A — DEVICEA finger worn OSA home sleep test (HST) diagnostic device
- Device B — DEVICEA wrist worn OSA home sleep test (HST) diagnostic device
- Device C — DEVICERing: wellness device
- Device D — DEVICETorso and limb worn patches
- Device E — DEVICEAn eye mask
- Screener A — DIAGNOSTIC_TESTA mobile app screener
Study Details
Resmed is the manufacturer of medical devices which screen, diagnose, treat and monitor people with sleeping and respiratory disorders, such as obstructive sleep apnea (OSA). From time to time, for regulatory, quality, and marketing purposes, there may be a need to test the various products performance against PSG (gold standard technology), and other products. The purpose of this study is: 1. Products performance against PSG 2. comparison against other products, and 3. Assessments of potential new technologies
Key Dates
- First listed
- Mar 20, 2026
- Start date
- Apr 30, 2026
- Status verified
- Mar 2026
- Primary completion
- Oct 31, 2026
- Completion
- Oct 31, 2026
Study Design
- Enrollment
- 90 participants (estimated)
Arms
- Arm: OSASuspected of obstructive sleep apnea and about to undergo assessment
Primary Outcome Measure
Sensitivity [ Time Frame: Single night PSG ]
Central Contacts
- Alison Wimms, PhD02 8884 2203
Related Studies
- Computer Models of Airways in Children and Young Adults With Sleep Apnea and Down SyndromeEnrolling By Invitation · Children's Hospital Medical Center, Cincinnati · Cincinnati, Ohio
- Magnetic Apnea Prevention(MAGNAP) Device to Treat Obstructive Sleep Apnea:First-In-Human Study of Feasibility and SafetyRecruiting · Michael Harrison · San Francisco, California
- Neurocognitive and Health Impact of Sleep Apnea in Elderly Veterans With Comorbid COPDRecruiting · VA Office of Research and Development · Detroit, Michigan
- Predicting Cardiometabolic Risk in Mild-to-Moderate Obstructive Sleep Apnea: Inflammation vs. Apnea/Hypopnea IndexEnrolling By Invitation · Milton S. Hershey Medical Center · Hershey, Pennsylvania